Sequana Medical 2022 BioCapital Europe Investor Presentation

Sequana Medical is a biotech company developing innovative therapies for diuretic-resistant fluid overload, including the alfapump® system for refractory ascites and DSR® therapy. The company presented at BioCapital Europe in March 2022, highlighting its pipeline and regulatory progress in Europe and clinical investigations globally.